1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP...
Biologics
FY 2024 and 2025 Total Revenue Guidance Increased to More Than $415 Million and $465 Million, RespectivelyFY 2024 and 2025...